DoseMeRx Description

DoseMeRx stands as the first and largest Bayesian dosing platform worldwide, tailored specifically for clinical use. Accelerate your journey toward clinical objectives with our proven platform, which notably enhances patient outcomes while reducing expenses. Uniquely, we are the sole Bayesian dosing solution globally that holds HITRUST certification, providing you with peace of mind regarding the utmost protection and integrity of patient data. Experience seamless continuity of care throughout your healthcare system with just a few simple steps. Easily standardize workflows and fine-tune your therapeutic drug monitoring initiatives. Our diverse array of drug models spans multiple therapeutic fields, such as vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation management, as well as oncology and pediatrics, ensuring comprehensive support for a wide range of clinical scenarios. This versatility empowers healthcare providers to deliver tailored treatment solutions effectively.

Pricing

Free Trial:
Yes

Integrations

Reviews

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Company Details

Company:
DoseMeRx
Year Founded:
2014
Headquarters:
United States
Website:
doseme-rx.com

Media

DoseMeRx Screenshot 1
Recommended Products
Our Free Plans just got better! | Auth0 Icon
Our Free Plans just got better! | Auth0

With up to 25k MAUs and unlimited Okta connections, our Free Plan lets you focus on what you do best—building great apps.

You asked, we delivered! Auth0 is excited to expand our Free and Paid plans to include more options so you can focus on building, deploying, and scaling applications without having to worry about your security. Auth0 now, thank yourself later.
Try free now

Product Details

Platforms
Web-Based
Types of Training
Training Docs
Webinars
Customer Support
Business Hours
Live Rep (24/7)
Online Support

DoseMeRx Features and Options

DoseMeRx User Reviews

Write a Review
  • Previous
  • Next